Bruker Overview
Bruker Target Price
Analysts' 12-month price predictions for BRKR.
Get informed when a big investor buys or sells
+ FollowShare Price
$61.64
Average Target Price
$50.75
17.7% downside
17.7% downside4 analysts in the last 4 months
High: $60 | Low: $45
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-24 | UBS | $60 | 2.7% downside |  |
| 2026-05-08 | Stifel NicolausDaniel Arias | $45 | 27% downside | |
| 2026-05-07 | UBS | $45 | 27% downside | |
| 2026-05-07 | BarclaysLuke Sergott | $53 | 14% downside | |
| 2026-02-13 | Goldman SachsEvie Koslosky | $35 | 43.2% downside | |
| 2026-02-13 | UBS | $49 | 20.5% downside | |
| 2026-02-13 | BarclaysLuke Sergott | $50 | 18.9% downside | |
| 2026-02-12 | Jefferies | $50 | 18.9% downside | |
| 2026-01-26 | Guggenheim | $58 | 5.9% downside | |
| 2026-01-05 | GuggenheimSubbu Nambi | $53 | 14% downside | |
| 2025-12-15 | Wells FargoBrandon Couillard | $55 | 10.8% downside | |
| 2025-12-15 | Barclays | $55 | 10.8% downside | |
| 2025-12-10 | Wolfe Research | $60 | 2.7% downside | |
| 2025-12-09 | Goldman Sachs | $40 | 35.1% downside | |
| 2025-11-20 | Redburn Partners | $60 | 2.7% downside | |
| 2025-11-04 | UBS | $43 | 30.2% downside | |
| 2025-11-04 | Barclays | $45 | 27% downside | |
| 2025-10-02 | Barclays | $40 | 35.1% downside | |
| 2025-08-05 | Stifel NicolausDaniel Arias | $40 | 35.1% downside | |
| 2025-08-04 | BarclaysLuke Sergott | $43 | 30.2% downside | |
| 2025-08-04 | Jefferies | $60 | 2.7% downside | |
| 2024-12-19 | GuggenheimSubbu Nambi | $72 |  16.8% upside | |
| 2024-09-23 | CitigroupPatrick Donnelly | $80 | 29.8% upside | |
| 2024-08-27 | Wells FargoBrandon Couillard | $78 | 26.5% upside | |
| 2024-05-20 | Stifel NicolausDaniel Arias | $77 | 24.9% upside | |
| 2021-05-05 | J.P. MorganTycho Peterson | $60 | 2.7% downside | |